Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 143 Carcinoma, Neuroendocrine 56 Thyroid Cancer, Papillary 54 Pheochromocytoma 50 Thyroid Neoplasms 41 Paraganglioma 41 Pituitary Neoplasms 37 Adrenocortical Carcinoma 31 Neoplasms 30 Multiple Endocrine Neoplasia Type 1 29 Gastro-enteropancreatic neuroendocrine tumor 29 Thyroid Carcinoma, Anaplastic 23 Small Cell Lung Carcinoma 21 Lung Neoplasms 21 Carcinoid Tumor 20 Sarcoma 19 Breast Neoplasms 19 Neoplasm Metastasis 18 Carcinoma, Non-Small-Cell Lung 18 Adenoma, Islet Cell 18 Melanoma 17 Carcinoma, Hepatocellular 17 Prostatic Neoplasms 15 Pancreatic Neoplasms 15 Ovarian Neoplasms 15 Neuroblastoma 15 Colorectal Neoplasms 15 Carcinoma, Renal Cell 15 Adrenal Gland Neoplasms 15 Adenocarcinoma, Follicular 15

Interventions

Serum Albumin 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Intestinal Neuroendocrine Tumor × Endocrine × 1 year × Clear all

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡